Download PDF
Thromb Haemost 1968; 20(03/04): 561-573
DOI: 10.1055/s-0038-1651299
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Assay of the Antifibrinolytic Activity in Human Plasma by Means of the Lysis Time Method

J Ygge
1   From Medical Department II, University of Göteborg, Sahlgrenska Hospital, Göteborg, Sweden
,
W Berg
1   From Medical Department II, University of Göteborg, Sahlgrenska Hospital, Göteborg, Sweden
,
K Korsan-Bengtsen
1   From Medical Department II, University of Göteborg, Sahlgrenska Hospital, Göteborg, Sweden
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

A one-stage lysis time method to determine the total antifibrinolytic activity of human plasma is described. Purified fibrinogen, thrombin, plasminogen, and urokinase were used in the test system. The necessity of using a high plasminogen concentration compared with the urokinase concentration is pointed out. The concentration of the reagents has to be carefully standardized.

A straight line will be obtained in a semi-logarithmic system when plasma dilutions are plotted against. The validity of this relation is investigated when the concentrations of plasminogen, fibrinogen, and urokinase are varied. It is also shown that this relation is valied when the antifibrinolytic activity is increased postoperatively and after delivery.

The antifibrinolytic activity is expressed as a percentage of the activity of a standard plasma. The standard plasma does not change its antifibrinolytic activity during storage at —20° C for at least three months.

The error of the method is about 2%.

Finally, the present report includes an experiment, the result of which makes it probable that the main action of plasma tested in this one-stage lysis time system is an antiplasmin activity.

 

  • References

  • 1 Bennet N.B. A method for the quantitative assay of inhibitor of plasminogen activation in human serum. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 17: 12
    PubMedGoogle Scholar
  • 2 Berg W, Korsan-Bengtsen K. Separation of human fibrinogen and plasminogen by means of gel filtration. Thrombos. Diathes. haemorrh. (Stuttg.) 1963; 9: 151
    PubMedGoogle Scholar
  • 3 Berg W, Korsan-Bengtsen K, Ygge J. Plasminogen assay by means of the lysis time method. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 14: 127
    PubMedGoogle Scholar
  • 4 Berg W, Korsan-Bengtsen K, Ygge J. Human and bovine plasminogen-free thrombin, purified by means of gel filtration and ion exchange chromatography. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 15: 501
    PubMedGoogle Scholar
  • 5 Berg W, Korsan-Bengtsen K, Ygge J. Preparation of human plasminogen suitable as substrate for quantitative determination of plasminogen activators. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 15: 511
    PubMedGoogle Scholar
  • 6 Berg W, Korsan-Bengtsen K, Ygge J. Determination of plasminogen in human plasma by the lysis time method. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 16: 1
    PubMedGoogle Scholar
  • 7 Berg W, Korsan-Bengtsen K, Ygge J. Theoretical basis and standardization of the one stage “Lysis Time” method for determination of urokinase. Thrombos. Diathes. haemorrh. (Stuttg.).(In press.).
    PubMedGoogle Scholar
  • 8 Bergström K, Blombäck B, Kleen G. Studies on the plasma fibrinolytic activity in a case of liver cirrhosis. Acta med. scand 1960; 168: 291
    PubMedGoogle Scholar
  • 9 Blombäck B. On the properties of fibrinogen and fibrin. Arkiv Kemi 1958; 12: 99
    PubMedGoogle Scholar
  • 10 Brahman P, Astrup T. Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand. J. clin. Lab. Invest 1963; 15: 603
    CrossrefPubMedGoogle Scholar
  • 11 Jacobsen C.D. The antiplasmin activity of human plasma and serum and its dependence on ions. Scand. J. clin. Lab. Invest 1964; 16: 383
    CrossrefPubMedGoogle Scholar
  • 12 Jacobsson K. II. Studies on the trypsin and plasmin inhibitors in human blood serum. Scand. J. clin. Lab. Invest 1955. Suppl 14
    Google Scholar
  • 13 Lauritsen O.S. The influence of time upon the inhibition of plasmin by normal, human serum. Scand. J. clin. Lab. Invest 1966; 18: 69
    CrossrefPubMedGoogle Scholar
  • 14 Maki M, Saito P.L, Yoneya T. Method of antiplasmin assay in human plasma. Tohoku J. exp.Med 1964; 83: 168
    PubMedGoogle Scholar
  • 15 Mehl J.W, O’Connell W, De Groot J. Macroglobulin from human plasma which forms an enzymatically active compound with trypsin. Science 1964; 145: 821
    CrossrefPubMedGoogle Scholar
  • 16 Morrison P. Preparation and properties of serum and plasma proteins. XV. Some factors influencing the quantitative determination of fibrinogen. J. Amer. ehem. Soc 1947; 69 (02) 2723
    CrossrefPubMedGoogle Scholar
  • 17 Nilsson I.M, Krook H, Sternby N.-H, Söderberg E, Söderström N. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta med. scand 1961; 169: 323
    PubMedGoogle Scholar
  • 18 Norman P.S. Studies on the plasmin system II. Inhibition of plasmin by serum or plasma. J. exp.Med 1958; 108: 53
    CrossrefPubMedGoogle Scholar
  • 19 Remmert L.P, Cohen P.P. Partial purification and properties of a proteolytic enzyme of human serum. J. biol. Chem 1949; 181: 431
    PubMedGoogle Scholar
  • 20 Rimon A, Shamash Y, Shapiro B. The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin. J. biol. Chem 1966; 241: 5102
    PubMedGoogle Scholar